{"transactions":[{"id":3034107,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":146699,"kind":"person","name":"Skerlj Renato","position":1,"cik":"0001814632","reported_name":"Skerlj Renato","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-09-10T12:36:45.000Z","date":"2020-09-09","kind":"sale","acquired":false,"shares":5834,"price":8.05,"value":46963.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes sale of 1,660 shares to cover personal income tax obligation upon settlement of restricted stock unit award."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.57 to $8.96, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Of the shares of common stock reported, 11,666 shares represent unvested restricted stock units."}],"balance_after":42076,"source":{"system":"sec-edgar","filing":"0001628280-20-013423","document":"wf-form4_159974138846947.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501697/000162828020013423/wf-form4_159974138846947.xml","form_type":"4"}},{"id":3053604,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":146699,"kind":"person","name":"Skerlj Renato","position":1,"cik":"0001814632","reported_name":"Skerlj Renato","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-08-19T00:14:30.000Z","date":"2020-08-17","kind":"grant","acquired":true,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents restricted stock units issued to the Reporting Person.  Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer and has no expiration date.  One third of the shares underlying the restricted stock unit award vested on August 17, 2020.  One third of the shares will vest on August 17, 2021, and one third of the shares will vest on August 17, 2022, subject to the Reporting Person providing continuous service to the Issuer on such dates.  Shares in respect of the vested portion of the award must be delivered no later than March 15 of the calendar year following the year in which vesting occurs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Of the shares of common stock reported, 11,666 shares represent unvested restricted stock units."}],"balance_after":47910,"source":{"system":"sec-edgar","filing":"0001628280-20-012844","document":"wf-form4_159779605540870.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501697/000162828020012844/wf-form4_159779605540870.xml","form_type":"4"}},{"id":3053603,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":146699,"kind":"person","name":"Skerlj Renato","position":1,"cik":"0001814632","reported_name":"Skerlj Renato","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-08-19T00:14:30.000Z","date":"2020-08-14","kind":"grant","acquired":true,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units issued to the Reporting Person.  Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer and has no expiration date.  One third of the shares underlying the restricted stock unit award vested on August 14, 2020.  One third of the shares will vest on August 14, 2021, and one third of the shares will vest on August 14, 2022, subject to the Reporting Person providing continuous service to the Issuer on such dates.  Shares in respect of the vested portion of the award must be delivered no later than March 15 of the calendar year following the year in which vesting occurs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Of the shares of common stock reported, 5,833 shares represent unvested restricted stock units."}],"balance_after":39160,"source":{"system":"sec-edgar","filing":"0001628280-20-012844","document":"wf-form4_159779605540870.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501697/000162828020012844/wf-form4_159779605540870.xml","form_type":"4"}},{"id":3113019,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":146699,"kind":"person","name":"Skerlj Renato","position":1,"cik":"0001814632","reported_name":"Skerlj Renato","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-06-11T21:32:34.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on June 10, 2021, with the remainder vesting in equal installments of 2.0833% of the shares subject to the option on the last day of each successive month thereafter for a period of 36 months, subject to the Reporting Person continuing to provide services through each such date."}],"balance_after":50000,"derivative":{"exercise_price":8.69,"expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001628280-20-009293","document":"wf-form4_159191113695970.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501697/000162828020009293/wf-form4_159191113695970.xml","form_type":"4"}}]}